| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $43,898,023 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K23DK128562 | Classical and Alternative Renin-Angiotensin System Dysregulation in Sepsis-Associated AKI: A Reverse Translation Approach | 000 | 3 | NIH | 11/21/2023 | $157,563 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R35GM141478 | Relative adrenal insufficiency as a risk factor and an endotype for sepsis | 000 | 4 | NIH | 4/16/2024 | $344,250 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG068055 | Identifying Associations between Brain Iron, Neurocognitive Networks and Protective Factors | 000 | 4 | NIH | 3/19/2024 | $570,430 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AA028246 | Cross-Tailoring Integrative Alcohol and Risky Sex Feedback for College Students: A Hybrid Type 1 Effectiveness-Implementation Trial | 000 | 4 | NIH | 2/7/2024 | $577,019 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK124774 | Circadian Regulation of Metabolic Risk in Mice and Women: Role of Estrogen and Time-Restricted Feeding | 000 | 4 | NIH | 1/29/2024 | $509,460 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS121193 | Functional Diversity of Reactive Astrocytes in Spinal Cord Repair | 001 | 4 | NIH | 4/11/2024 | $26,775 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS121193 | Functional Diversity of Reactive Astrocytes in Spinal Cord Repair | 000 | 4 | NIH | 3/27/2024 | $344,250 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS119165 | Translational Approaches to Mitigate Enhanced Alzheimer?s Disease Risk Following a Mild TBI | 000 | 2 | NIH | 4/16/2024 | $382,500 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AG083820 | Deciphering genetics of PLCG2 alternative splicing to understand AD risk | 000 | 1 | NIH | 4/15/2024 | $415,626 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01HL163589 | Targeting Endothelial Cell Mineralocorticoid Receptor Against Aortic Aneurysm in Females | 000 | 1 | NIH | 3/8/2024 | $649,718 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21NS137256 | Combinatorial approach to restore breathing after spinal cord injury | 000 | 1 | NIH | 3/19/2024 | $222,109 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | G08LM014412 | DASH-ing to Heart Health: Supporting Low-Income African American Women with an Interactive "Meals that Heal" Resource Book | 000 | 1 | NIH | 12/20/2023 | $118,770 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R00CA249048 | A pro-metastatic secretory program activated by epithelial-to-mesenchymal transition | 001 | 3 | NIH | 4/23/2024 | $18,022 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R00CA249048 | A pro-metastatic secretory program activated by epithelial-to-mesenchymal transition | 000 | 3 | NIH | 3/12/2024 | $224,101 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AI180274 | Molecular mechanisms of Helicobacter pylori trans-kingdom DNA conjugation | 000 | 1 | NIH | 11/22/2023 | $192,814 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA282254 | Integrative Targeted Therapy for Melanoma | 000 | 1 | NIH | 3/22/2024 | $632,195 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA278989 | Mechanistic and structural insights into a new pro-metastatic collagen glucosyltransferase | 001 | 1 | NIH | 1/22/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA278989 | Mechanistic and structural insights into a new pro-metastatic collagen glucosyltransferase | 000 | 1 | NIH | 1/16/2024 | $593,786 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG070952 | Dynamic GABA and Glutamate Neurotransmission in Alzheimer?s Disease and Aging | 000 | 2 | NIH | 1/29/2024 | $596,810 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG084670 | Emerging role of PAD4 mediated TDP-43 citrullination in the neuropathology of LATE and Alzheimer?s Disease Related Dementias | 000 | 1 | NIH | 2/7/2024 | $690,893 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21NS135089 | Cannabidiol (CBD) as a Potential Therapeutic for Experimental Subarachnoid Hemorrhage | 000 | 1 | NIH | 12/5/2023 | $229,500 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F32AR083259 | A multispecies system for elucidating proliferative control mechanisms during mammalian skin and musculoskeletal regeneration | 000 | 1 | NIH | 4/15/2024 | $74,292 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS127974 | Predictors and Biomarkers for VCID versus Cognitive Recovery after Stroke Thrombectomy in Rural Appalachia | 000 | 2 | NIH | 3/11/2024 | $512,407 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS127974 | Predictors and Biomarkers for VCID versus Cognitive Recovery after Stroke Thrombectomy in Rural Appalachia | 000 | 2 | NIH | 3/11/2024 | $108,515 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS127974 | Predictors and Biomarkers for VCID versus Cognitive Recovery after Stroke Thrombectomy in Rural Appalachia | 001 | 2 | NIH | 4/11/2024 | $36,237 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS127974 | Predictors and Biomarkers for VCID versus Cognitive Recovery after Stroke Thrombectomy in Rural Appalachia | 001 | 2 | NIH | 4/11/2024 | $12,056 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21NS128749 | Development of a Novel Animal Model for Spinal Cord Injury with Sepsis | 000 | 2 | NIH | 4/3/2024 | $190,837 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA058933 | Neurobehavioral mechanisms underlying xylazine and fentanyl co-use and withdrawal | 000 | 2 | NIH | 4/23/2024 | $502,057 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K01AG070279 | Cognitive Aging Trajectories in Survivors of Trauma | 000 | 2 | NIH | 1/17/2024 | $125,795 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P20GM148326 | Center of Biomedical Research Excellence in CNS Metabolism | 000 | 2 | NIH | 4/22/2024 | $1,917,850 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01GM150200 | Study of PTPRF-Mediated Regulation of Wnt Signaling | 000 | 2 | NIH | 2/27/2024 | $312,413 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AI178652 | Genetic screen to define the regulation of beta-hemolysin toxin expression in Streptococcus agalactiae | 000 | 2 | NIH | 4/16/2024 | $229,500 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R33DC019602 | Hearing Healthcare Assessment in Rural Communities (HHARC) | 001 | 3 | NIH | 10/27/2023 | $29,645 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21ES035320 | Impact of Landfill Mitigation Efforts to Reduce Air Toxics in Bristol, Tennessee and Virginia | 000 | 2 | NIH | 4/2/2024 | $191,846 |
| | 2024 | 2024 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R13OH012359 | SouthON Conference Grant | 01 | 3 | CDC | 2/5/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R13OH012359 | SouthON Conference Grant | 00 | 3 | CDC | 12/1/2023 | $20,000 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31MH132194 | The Experience and Regulation of Posttraumatic Shame among Women with Histories of Interpersonal Trauma | 000 | 2 | NIH | 11/15/2023 | $47,694 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | U01DK135111 | Restoration of Impaired Awareness of Hypoglycemia U01 Consortium: University of Kentucky | 000 | 2 | NIH | 4/18/2024 | $654,502 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21NS131903 | Mechanism and Therapeutic Potential of CBD to Repair Blood-Brain Barrier Dysfunction in Epilepsy | 000 | 2 | NIH | 3/19/2024 | $191,250 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG082142 | MicroRNA lipid-nanoparticle based therapy targets neuroinflammation and ApoE dysregulation in Alzheimer?s disease | 000 | 2 | NIH | 12/14/2023 | $600,292 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R25NS130963 | UKNeu-PREP: University of Kentucky Neuroscience Postbaccalaureate Research Education Program | 001 | 2 | NIH | 2/27/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R25NS130963 | UKNeu-PREP: University of Kentucky Neuroscience Postbaccalaureate Research Education Program | 000 | 2 | NIH | 2/16/2024 | $433,139 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AI169231 | Function of the type 7 secretion system in Group B Streptococcus | 000 | 2 | NIH | 10/24/2023 | $175,989 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AI175220 | Chlamydia type III effectors affecting the host actin-based cytoskeleton | 000 | 2 | NIH | 1/5/2024 | $504,704 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31HL170558 | The myosin super-relaxed state and human dilated cardiomyopathy | 001 | 1 | NIH | 3/1/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31HL170558 | The myosin super-relaxed state and human dilated cardiomyopathy | 000 | 1 | NIH | 3/1/2024 | $34,042 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA284532 | Fatty Acid Synthase as a Novel Molecular Target for Colon Cancer Treatment | 000 | 1 | NIH | 2/19/2024 | $402,968 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21CA285253 | Novel Strategy to Augmenting Immunotherapy against Melanoma | 000 | 1 | NIH | 2/29/2024 | $177,259 |
| | 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AA030775 | Influence of Orexin Antagonism on Motivation for Alcohol | 000 | 1 | NIH | 3/13/2024 | $526,984 |
|
